Lataa...
Immunogenicity and Protective Effect of a Virus-Like Particle Containing the SAG1 Antigen of Toxoplasma gondii as a Potential Vaccine Candidate for Toxoplasmosis
This study was carried out to evaluate the vaccination effect of a virus-like particle (VLP) including the surface antigen 1 (SAG1) of Toxoplasma gondii as a potential vaccine for toxoplasmosis. The SAG1 virus-like particles (SAG1-VLPs) were expressed by Sf9 cells, and their expression was confirmed...
Tallennettuna:
| Julkaisussa: | Biomedicines |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7235809/ https://ncbi.nlm.nih.gov/pubmed/32325746 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines8040091 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|